A series of new salinomcyin triazole analogues were synthesized through convenient CuAAC reactions. Salinomcyin triazole derivatives modified at the C20 hydroxyl group displayed potent antitumour activities. Salinomycin triazole dimers were 3.27–4.97 times more toxic than salinomycin against breast cancer cell line MCF-7.